PUMA pathway is a weak link in breast cancer metastasis

December 11, 2017, JCI Journals

Substantial advancements have improved the success of chemotherapy, radiation, and surgical treatments for primary breast cancers. However, breast cancer that has spread, or metastasized, to other parts of the body remains a challenge to cure. It is difficult to predict whether a tumor will recur and metastasize, and uncertainty can lead to inadequate or overaggressive treatment.

The cells that initiate metastasis often resemble , a population of that enable development during adulthood. During pregnancy, hormonal signaling activates healthy stem cells, which initiate mammary gland remodeling that supports breast milk production. Now, a new study from Jay Desgrosellier's lab at UCSD has used the activation signature of mammary stem cells to identify vulnerabilities in stem-like metastasis-initiating cells.

In a study published this week in the JCI, Sun et al. report that low-level expression of a protein called PUMA (p53-upregulated modulator of apoptosis) distinguishes stem-like cells in cancer patients who experienced tumor recurrence during a 10-year follow-up period. The cells' ability to suppress PUMA levels was critical to their survival-enhancing PUMA expression selectively depleted stem-like properties and reduced metastasis, whereas reducing PUMA restored metastasis in cultured cells.

Together, these findings expose a possible Achilles heel in aggressive breast cancers that may enable earlier identification and better targeting of metastases. Present limitations in the ability to predict and eliminate aggressive cancer cells likely contribute to the majority of deaths from , but the development of adjuvant approaches that exploit their weaknesses may greatly improve disease outcomes.

Explore further: Researchers identify oestrogen receptor stem cells in the mammary gland.

More information: Qi Sun et al, Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis, Journal of Clinical Investigation (2017). DOI: 10.1172/JCI93707

Related Stories

Researchers identify oestrogen receptor stem cells in the mammary gland.

August 16, 2017
One of the key questions in stem cell and cancer biology is to understand the cellular hierarchy governing tissue development and maintenance and the cancer cell of origin. In a study published in Cell Reports, researchers ...

Fighting cancer: Natural and synthetic progestin therapies in post-menopausal women help breast cancer grow and spread

July 12, 2017
Hormone replacement therapies, or medications containing female hormones that substitute those no longer produced by the body, often are prescribed to reduce the effects of menopausal symptoms in women. Research has indicated ...

MicroRNA molecule may serve as biomarker, target for brain metastases in breast cancer patients

February 5, 2013
Researchers have identified two molecules that could potentially serve as biomarkers in predicting brain metastases in patients with breast cancer, according to data published in Cancer Research, a publication of the American ...

How breast cancer usurps the powers of mammary stem cells

August 11, 2014
During pregnancy, certain hormones trigger specialized mammary stem cells to create milk-producing cells essential to lactation. Scientists at the University of California, San Diego School of Medicine and Moores Cancer Center ...

ONC201 may inhibit cancer stem cell self-renewals by altering their gene expression

August 2, 2017
ONC201 may inhibit cancer stem cell self-renewals by altering their gene expression, according to a study published August 2, 2017 in the open-access journal PLOS ONE by Varun Vijay Prabhu from Oncoceutics, Inc., USA and ...

Study identifies RNA molecule that shields breast cancer stem cells from immune system

May 22, 2017
Researchers from Princeton University's Department of Molecular Biology have identified a small RNA molecule that helps maintain the activity of stem cells in both healthy and cancerous breast tissue. The study, which will ...

Recommended for you

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Delving where few others have gone, leukemia researchers open new path

October 15, 2018
A Wilmot Cancer Institute study uncovers how a single gene could be at fault in acute myeloid leukemia (AML), one of the deadliest cancers. The breakthrough gives researchers renewed hope that a gene-targeted therapy could ...

3-D mammography detected 34% more breast cancers in screening

October 15, 2018
In traditional mammography screening, all breast tissue is captured in a single image. Breast tomosynthesis, on the other hand, is three-dimensional and works according to the same principle as what is known as tomography. ...

More clues revealed in link between normal breast changes and invasive breast cancer

October 15, 2018
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process—changes in mammary glands to accommodate breastfeeding—uses a molecular process believed ...

Cancer stem cells use 'normal' genes in abnormal ways

October 12, 2018
CDK1 is a "normal" protein—its presence drives cells through the cycle of replication. And MHC Class I molecules are "normal" as well—they present bits of proteins on the surfaces of cells for examination by the immune ...

Obesity linked to increased risk of early-onset colorectal cancer

October 12, 2018
Women who are overweight or obese have up to twice the risk of developing colorectal cancer before age 50 as women who have what is considered a normal body mass index (BMI), according to new research led by Washington University ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.